Home/Filings/4/0001209191-21-013410
4//SEC Filing

LIDGARD GRAHAM PETER 4

Accession 0001209191-21-013410

CIK 0001124140other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:42 PM ET

Size

8.0 KB

Accession

0001209191-21-013410

Insider Transaction Report

Form 4
Period: 2021-02-19
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2021-02-19+12,44912,449 total
    Common Stock (12,449 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    4,673
  • Common Stock

    (indirect: By 401(k))
    12,725
  • Common Stock

    35,596
Footnotes (3)
  • [F1]In addition to the shares of Common Stock reported on this Form 4, which total 52,994 shares, Mr. Lidgard also holds, in the aggregate, an additional 131,468 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001216274

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:42 PM ET
Size
8.0 KB